Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Original Investigation Glucagon-Like Peptide-1 Receptor Agonists and Chronic Cough: Chronic cough may occur in patients using glucagon-like peptide-1 receptor agonists (GLP-1RAs), even in the absence of gastroesophageal reflux disease (GERD)
While there is no direct pharmacological interaction between injectable GLP-1 receptor agonists and levothyroxine, the delayed gastric emptying caused by these medications could potentially affect the absorption of levothyroxine
In some cases, healthcare providers may consider delaying dose escalation to ensure optimal tolerance and minimize potential side effects during the initial phase of treatment
Compounded via local clinic: Find a licensed clinician our peptide therapy directory lists verified clinics
US$ 20.56
US$ 25.55
US$ 20.41
US$ 20.14
US$ 21.73
